Mahdi et al., 2021 - Google Patents
Genomic analyses of high‐grade neuroendocrine gynecological malignancies reveal a unique mutational landscape and therapeutic vulnerabilitiesMahdi et al., 2021
View PDF- Document ID
- 12809969778125943809
- Author
- Mahdi H
- Joehlin‐Price A
- Elishaev E
- Dowlati A
- Abbas A
- Publication year
- Publication venue
- Molecular Oncology
External Links
Snippet
High‐grade neuroendocrine carcinoma of gynecologic origin (NEC‐GYN) is a highly aggressive cancer that often affects young women. The clinical management of NEC‐GYN is typically extrapolated from its counterpart, small cell carcinoma of the lung (SCLC), but …
- 230000000869 mutational 0 title abstract description 22
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/574—Immunoassay; Biospecific binding assay for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57415—Specifically defined cancers of breast
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
- C12Q1/6886—Hybridisation probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
- G06F19/18—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for functional genomics or proteomics, e.g. genotype-phenotype associations, linkage disequilibrium, population genetics, binding site identification, mutagenesis, genotyping or genome annotation, protein-protein interactions or protein-nucleic acid interactions
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
- G06F19/22—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for sequence comparison involving nucleotides or amino acids, e.g. homology search, motif or SNP [Single-Nucleotide Polymorphism] discovery or sequence alignment
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
- G06F19/28—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for programming tools or database systems, e.g. ontologies, heterogeneous data integration, data warehousing or computing architectures
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Yan et al. | Multi-region sequencing unveils novel actionable targets and spatial heterogeneity in esophageal squamous cell carcinoma | |
Decarvalho et al. | Discordant inheritance of chromosomal and extrachromosomal DNA elements contributes to dynamic disease evolution in glioblastoma | |
Chen et al. | Genomic landscape of lung adenocarcinoma in East Asians | |
Thomsen et al. | Comprehensive multiregional analysis of molecular heterogeneity in bladder cancer | |
Serratì et al. | Next-generation sequencing: advances and applications in cancer diagnosis | |
Mamlouk et al. | DNA copy number changes define spatial patterns of heterogeneity in colorectal cancer | |
Bi et al. | Genomic landscape of high-grade meningiomas | |
Abraham et al. | Small genomic insertions form enhancers that misregulate oncogenes | |
Nassar et al. | Genomic landscape of carcinogen-induced and genetically induced mouse skin squamous cell carcinoma | |
Kanchi et al. | Integrated analysis of germline and somatic variants in ovarian cancer | |
Meiller et al. | Multi-site tumor sampling highlights molecular intra-tumor heterogeneity in malignant pleural mesothelioma | |
Schoppmann et al. | Novel clinically relevant genes in gastrointestinal stromal tumors identified by exome sequencing | |
Burdett et al. | Multiomic analysis of homologous recombination-deficient end-stage high-grade serous ovarian cancer | |
WO2020136133A1 (en) | Tumor classification based on predicted tumor mutational burden | |
Mirhadi et al. | Integrative analysis of non-small cell lung cancer patient-derived xenografts identifies distinct proteotypes associated with patient outcomes | |
Masoodi et al. | Evolution and impact of subclonal mutations in papillary thyroid cancer | |
Ashford et al. | A CATH domain functional family based approach to identify putative cancer driver genes and driver mutations | |
Liu et al. | Targeted transcriptome analysis using synthetic long read sequencing uncovers isoform reprograming in the progression of colon cancer | |
Chen et al. | Genetic profile of non‐small cell lung cancer (NSCLC): A hospital‐based survey in Jinhua | |
Singh et al. | Intratumoral morphologic and molecular heterogeneity of rhabdoid renal cell carcinoma: challenges for personalized therapy | |
Kim et al. | Real‐world utility of next‐generation sequencing for targeted gene analysis and its application to treatment in lung adenocarcinoma | |
Arendt et al. | PIK3CA is recurrently mutated in canine mammary tumors, similarly to in human mammary neoplasia | |
Mathioudaki et al. | Targeted sequencing reveals the somatic mutation landscape in a Swedish breast cancer cohort | |
Mahdi et al. | Genomic analyses of high‐grade neuroendocrine gynecological malignancies reveal a unique mutational landscape and therapeutic vulnerabilities | |
Guo et al. | The landscape of genetic alterations stratified prognosis in oriental pancreatic cancer patients |